0001181431-13-017026.txt : 20130314 0001181431-13-017026.hdr.sgml : 20130314 20130314180210 ACCESSION NUMBER: 0001181431-13-017026 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130311 FILED AS OF DATE: 20130314 DATE AS OF CHANGE: 20130314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaldor Stephen W CENTRAL INDEX KEY: 0001507502 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34641 FILM NUMBER: 13691570 MAIL ADDRESS: STREET 1: C/O FURIEX PHARMACEUTICALS, INC. STREET 2: 3900 PARAMOUNT PARKWAY, SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001484478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271197863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-456-7800 MAIL ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: PPD Therapeutics, Inc. DATE OF NAME CHANGE: 20100218 4/A 1 rrd374145.xml FORM 4/A X0306 4/A 2013-03-11 2013-03-13 0 0001484478 Furiex Pharmaceuticals, Inc. FURX 0001507502 Kaldor Stephen W C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560 1 0 0 0 Common Stock 2013-03-11 4 M 0 5379 13.94 A 5379 D Common Stock 2013-03-11 4 S 0 5379 41.74 D 0 D Common Stock 2013-03-12 4 M 0 973 13.94 A 973 D Common Stock 2013-03-12 4 S 0 973 40.71 D 0 D Common Stock 2013-03-13 4 M 0 1648 13.94 A 1648 D Common Stock 2013-03-13 4 S 0 1648 39.96 D 0 D Stock Options (to buy) 13.94 2013-03-11 4 M 0 5379 0.00 D 2021-05-19 Common Stock 5379 7633 D Stock Options (to buy) 13.94 2013-03-12 4 M 0 973 0.00 D 2021-05-19 Common Stock 973 6660 D Stock Options (to buy) 13.94 2013-03-13 4 M 0 1648 0.00 D 2021-05-19 Common Stock 1648 5012 D Stock Options (to buy) 13.45 2021-10-12 Common Stock 8825 8825 D Stock Options (to buy) 18.22 2022-05-24 Common Stock 17500 17500 D These options and underlying shares were previously incorrectly reported as 8,000 in the Form 4. This exercise of options was previously incorrectly reported as being included in the 8,000 referenced in footnote (1). The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. This Form 4 is being amended to report all transactions that occurred on March 11 and 12, 2013, although the only corrections are those identified in footnote (1). We have also included transactions not previously reported regarding an option exercise and shares sold on March 13, 2013. /s/ Alexander M. Donaldson, by Power of Attorney 2013-03-14